The Lancet Oncology, 1470-2045
Journal
Publications
- 2020
- Published
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Oct 2020, In: The Lancet Oncology. 21, 10, p. 1309-1316 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial
Daniel Rea & 8 others, , Oct 2020, In: The Lancet Oncology. 21, 10, p. 1296-1308 13 p.Research output: Contribution to journal › Article › peer-review
- Published
Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
Hisham Mehanna, 1 Sep 2020, In: The Lancet Oncology. 21, 9, p. e417Research output: Contribution to journal › Letter › peer-review
- Published
Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus
Hisham Mehanna & 28 others, , Jul 2020, In: The Lancet Oncology. 21, 7, p. e350-e359 10 p.Research output: Contribution to journal › Review article › peer-review
- Published
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
Roland Arnold, Jean-Baptiste Cazier, Helen Curley, Anshita Goel, Simon Hartley, Lennard Lee, Christopher Middleton, Gary Middleton & 11 others, , May 2020, In: The Lancet Oncology. 21, 5, p. 622-624 3 p.Research output: Contribution to journal › Comment/debate › peer-review
- Published
The economic burden of cancer care for Syrian refugees: a population-based modelling study
Ping Guo, May 2020, In: The Lancet Oncology. 21, 5, p. 637-644 8 p.Research output: Contribution to journal › Article › peer-review
- Published
Statistical significance and clinical evidence
Simon Gates, Mar 2020, In: The Lancet Oncology. 21, 3, p. e118Research output: Contribution to journal › Article › peer-review
- Published
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium
Melanie Calvert & 15 others, , 1 Feb 2020, In: The Lancet Oncology. 21, 2, p. e83-e96Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Mark Drayson, Dickens Pratt & 6 others, , Dec 2019, In: The Lancet Oncology. 20, 12, p. 1760-1772Research output: Contribution to journal › Article › peer-review
- Published
Carcinogenicity of some industrial chemical intermediates and solvents
William A. Stubbings, Nov 2019, In: The Lancet Oncology.Research output: Contribution to journal › Article › peer-review